一种无动于衷的全身性巨细胞瘤的病例对Avapritinib治疗有反应
1Department of Medicine Internal Medicine Resident, Scripps Mercy Hospital San Diego California USA.
Clinical case reports
|February 26, 2024
概括
低剂量阿瓦普利提尼布在治疗先进和迟的全身性乳腺细胞瘤方面表现有前途. 这种新药为患有这种罕见疾病的患者提供了潜在的治疗选择.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 系统性乳腺细胞瘤 (SM) 是一种罕见的骨髓增殖性瘤,其特征是乳腺细胞积累.
- 目前对MS的治疗策略因疾病严重程度和亚型而异.
- 晚期SM预后不好,需要新的治疗方法.
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K